Rhumbline Advisers I Bio, Inc. Transaction History

Rhumbline Advisers

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.23 - $0.46 $52,348 - $104,696	-227,601 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.3 - $0.61 $8,225 - $16,725	-27,419 Reduced 10.75%	227,601 $97,000
Q4 2021 Feb 10, 2022	SELL	$0.55 - $1.04 $2,506 - $4,740	-4,558 Reduced 1.76%	255,020 $140,000
Q3 2021 Nov 12, 2021	BUY	$1.06 - $1.52 $8,043 - $11,533	7,588 Added 3.01%	259,578 $275,000
Q2 2021 Aug 05, 2021	BUY	$1.22 - $1.65 $124,997 - $169,054	102,457 Added 68.52%	251,990 $381,000
Q1 2021 May 06, 2021	BUY	$1.18 - $2.62 $50,026 - $111,074	42,395 Added 39.57%	149,533 $230,000
Q4 2020 Feb 10, 2021	BUY	$1.05 - $2.24 $63,554 - $135,582	60,528 Added 129.86%	107,138 $112,000
Q3 2020 Nov 12, 2020	BUY	$1.7 - $6.41 $3,553 - $13,396	2,090 Added 4.69%	46,610 $95,000
Q2 2020 Aug 13, 2020	BUY	$0.87 - $2.46 $38,732 - $109,519	44,520 New	44,520 $99,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.8M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.